One Rare Disease Biotech Posts 97% Margins but the Faster Growing Rival Just Turned Its First Profit
Corcept Therapeutics (NASDAQ: CORT) and Amicus Therapeutics (NASDAQ: FOLD) delivered Q3 2025 results highlighting two rare ...
Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. From facial ...
A mother-of-two has shared the subtle warning sign that lead to both of her children being diagnosed with a rare type of ...
A mother has opened up on the rare health condition that both of her children have been diagnosed with. Both the parents ...
A long-established drug with a diverse medical history is drawing new attention for its potential role in treating an ...
AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, recently announced that the United States Food and Drug Administration (FDA) has ...
A Northwestern Medicine study has uncovered a promising new therapeutic approach for a rare genetic brain disorder, according ...
Inflammation is a vascular or blood vessel and cellular reaction in the human body to stimulus and trauma. It refers to your body's process of fighting against things that harm it, such as infections, ...
Scientists knew that obesity raises the risk of hypertension. Now Paul Cohen and Mascha Koenen have uncovered the ...
Scientists have found that a common oral bacterium known as the causative agent of tooth decay can affect the brain and ...
Mare BioInnovations launchd Ocythera led by Dr. Martin Petkovich with support of Dr. Don Cameron and acting CEO Joseph ...
CNW/ - adMare BioInnovations is proud to announce the creation of Ocythera, a new biopharmaceutical company dedicated to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback